Flu Is Relentless. Crispr Might Be Able to Shut It Down
Scientists at Melbourne’s Peter Doherty Institute for Infection and Immunity are working on a Crispr-based treatment — delivered as a nasal spray or injection — that could stop influenza infections by targeting the virus’s RNA and disrupting its ability to replicate inside human cells. The approach uses the Cas13 enzyme, Read more…






